Jenburkt Pharmaceuticals Limited, incorporated in 1985, was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.
Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc.
Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with curre ...nt Good Manufacturing Practices (GMP) requirements. In addition, it has a Research & Development unit duly approved by the Ministry of Science & Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market.
The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work - Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company.
In 2021-22, the Company launched a new OTC division ~ Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 2022-23.
Nervijen D3 tablets became the first brand in 2025 to reach a revenue target exceeding during the year.
1. Can I buy Jenburkt Pharmaceuticals Ltd from PL Capital? ›
Yes, you can invest in Jenburkt Pharmaceuticals Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Jenburkt Pharmaceuticals Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Jenburkt Pharmaceuticals Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Jenburkt Pharmaceuticals Ltd pay dividends? ›
Yes, Jenburkt Pharmaceuticals Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Jenburkt Pharmaceuticals Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.
3. What is the current share price of Jenburkt Pharmaceuticals Ltd ? ›
As of
16-01-2026 the share price for Jenburkt Pharmaceuticals Ltd. is 1110.9 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Jenburkt Pharmaceuticals Ltd ? ›
The 52-week high and low of Jenburkt Pharmaceuticals Ltd share price is ₹ 936.7 - ₹ 1410 as of
16-01-2026 .
PL Ringside View
Our fireside chat series where industry experts and top management share valuable insights for our clients
